Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12122773
Crystalline hydrate of a JAK inhibitor compound
granted -
US 12121540
CBL inhibitors and compositions for use in adoptive cell therapy
granted -
US 12123001
Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors
granted -
US 12121524
DNA-PK inhibitors
granted -
US 12116354
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 12116343
Inhibitors of APOL1 and methods of using same
granted -
US 12116346
Human plasma kallikrein inhibitors
granted -
US 12115163
Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor
granted -
US 12115156
Compositions of CXCR4 inhibitors and methods of preparation and use
granted -
US 12103907
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
granted -
US 12097199
Administration of SUMO-activating enzyme inhibitor and anti-CD20 antibodies
granted -
US 12097213
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy
granted -
US 12097210
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted -
US 12097262
mTORC1 inhibitors
granted -
US 2024307628
SYSTEMS AND METHODS FOR DELIVERY OF LIQUID PHARMACEUTICAL COMPOSITIONS IN PARTICULAR COMPRISING ONE OR MORE SGLT-2 INHIBITOR(S)
granted -
US 12083098
Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form β inhibitors
granted -
US 12084447
SHP2 phosphatase inhibitors and methods of use thereof
granted -
US 12083141
Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors
granted -
US 12083113
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted -
US 12084438
GCN2 inhibitors and uses thereof
granted -
US 12083137
Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors
granted -
US 12077515
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 12076324
Cancer treatments using combinations of CDK and ERK inhibitors
granted -
US 12077506
Indane derivatives as hypoxia inducible factor-2(α) inhibitors
granted